Home/Filings/4/0001209191-14-077800
4//SEC Filing

Auspex Pharmaceuticals, Inc. 4

Accession 0001209191-14-077800

CIK 0001454189operating

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 5:23 PM ET

Size

11.5 KB

Accession

0001209191-14-077800

Insider Transaction Report

Form 4
Period: 2014-12-22
Stamler David A
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2014-12-22$53.28/sh1,560$83,1182,083 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-12-222,66028,274 total
    Exercise: $0.90Exp: 2021-03-10Common Stock (2,660 underlying)
  • Sale

    Common Stock

    2014-12-22$53.92/sh1,100$59,316983 total
  • Exercise/Conversion

    Common Stock

    2014-12-22$0.90/sh+2,660$2,3943,643 total
Footnotes (5)
  • [F1]Includes 591 shares purchased through the Company's 2014 Employee Stock Purchase Plan ("ESPP") on May 20, 2014, and 392 shares purchased through the ESPP on November 20, 2014.
  • [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 23, 2014.
  • [F3]This transaction was executed in multiple trades at prices ranging from a low of $52.80 to a high of $53.64. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from a low of $53.71 to a high of $54.065. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]The original option grant to purchase 30,934 shares of common stock (split-adjusted) is subject to monthly vesting over a four-year period beginning on February 15, 2011.

Issuer

Auspex Pharmaceuticals, Inc.

CIK 0001454189

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001454189

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:23 PM ET
Size
11.5 KB